Citation 103521

FRYDMAN,B: MARTON,LJ: SUN,JS: NEDER,K: WITIAK,DT: LIU,AA: WANG,HM: MAO,Y: WU,HY: SANDERS,MM: LIU,LF:. (1997). INDUCTION OF DNA TOPOSOMERASE II-MEDIATED DNA CLEAVAGE BY BETA-LAPACHONE AND RELATED NAPHTHOQUINONES.. 57(4)

Citation Details

Title	INDUCTION OF DNA TOPOSOMERASE II-MEDIATED DNA CLEAVAGE BY BETA-LAPACHONE AND RELATED NAPHTHOQUINONES.
Authors	FRYDMAN,B: MARTON,LJ: SUN,JS: NEDER,K: WITIAK,DT: LIU,AA: WANG,HM: MAO,Y: WU,HY: SANDERS,MM: LIU,LF:
Year	1997
Volume	57
Issue	4

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOPOISOMERASE II INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
2	TOPOISOMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
3	ANTIYEAST ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	LAPACHONE,BETA:	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,BETA:	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,BETA:	ACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,BETA:	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,BETA:	ACTIVE
13	TOPOISOMERASE II INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	LAPACHONE,ALPHA:	WEAK ACTIVITY
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA:	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA:	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA:	ACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA:	ACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA:	ACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA: DEHYDRO:	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA: DEHYDRO:	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA: DEHYDRO:	ACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA: DEHYDRO:	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	LAPACHONE,ALPHA: DEHYDRO:	ACTIVE
24	TOPOISOMERASE II INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	MENADIONE	WEAK ACTIVITY
25	TOPOISOMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MENADIONE	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MENADIONE	ACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MENADIONE	ACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MENADIONE	ACTIVE
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MENADIONE	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	MENADIONE	ACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DUNNIONE	ACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DUNNIONE	ACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DUNNIONE	ACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DUNNIONE	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	DUNNIONE	ACTIVE

Citation 103521

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1